NO20064858L - Nye assosiasjon mellom en heterosyklisk forbindelse og et antioksidantmiddel, og farmasoytiske sammensetninger inneholdende dem - Google Patents

Nye assosiasjon mellom en heterosyklisk forbindelse og et antioksidantmiddel, og farmasoytiske sammensetninger inneholdende dem

Info

Publication number
NO20064858L
NO20064858L NO20064858A NO20064858A NO20064858L NO 20064858 L NO20064858 L NO 20064858L NO 20064858 A NO20064858 A NO 20064858A NO 20064858 A NO20064858 A NO 20064858A NO 20064858 L NO20064858 L NO 20064858L
Authority
NO
Norway
Prior art keywords
pharmaceutical compositions
compositions containing
heterocyclic compound
antioxidant agent
new association
Prior art date
Application number
NO20064858A
Other languages
English (en)
Inventor
Catherine Dacquet
Pascal Berthelot
Louis Casteilla
Luc Penicaud
Daniel-Henri Caignard
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of NO20064858L publication Critical patent/NO20064858L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Oppfinnelsen vedrører en assosiasjon omfattende en forbindelse som favoriserer lipid- og karbohydratmetabohsmene i kroppen og et antioksidantmiddel. Medikamenter.
NO20064858A 2004-03-31 2006-10-25 Nye assosiasjon mellom en heterosyklisk forbindelse og et antioksidantmiddel, og farmasoytiske sammensetninger inneholdende dem NO20064858L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0403359A FR2868313B1 (fr) 2004-03-31 2004-03-31 Nouvelle association entre un compose heterocyclique et un agent antioxydant et les compositions pharmaceutiques qui les contiennent
PCT/FR2005/000755 WO2005099694A1 (fr) 2004-03-31 2005-03-30 Association entre un compose heterocyclique et un agent antioxydant et son utilisation pour le traitement de l’obesite

Publications (1)

Publication Number Publication Date
NO20064858L true NO20064858L (no) 2006-10-25

Family

ID=34945535

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20064858A NO20064858L (no) 2004-03-31 2006-10-25 Nye assosiasjon mellom en heterosyklisk forbindelse og et antioksidantmiddel, og farmasoytiske sammensetninger inneholdende dem

Country Status (19)

Country Link
US (1) US20070167502A1 (no)
EP (1) EP1729767A1 (no)
JP (1) JP2007530643A (no)
KR (1) KR100842567B1 (no)
CN (1) CN100536842C (no)
AR (1) AR048355A1 (no)
AU (1) AU2005232420B8 (no)
BR (1) BRPI0509389A (no)
CA (1) CA2563104A1 (no)
EA (1) EA012966B1 (no)
FR (1) FR2868313B1 (no)
GE (1) GEP20094637B (no)
HK (1) HK1099689A1 (no)
MA (1) MA28467B1 (no)
MY (1) MY142039A (no)
NO (1) NO20064858L (no)
UA (1) UA86801C2 (no)
WO (1) WO2005099694A1 (no)
ZA (1) ZA200607798B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2894965B1 (fr) * 2005-12-20 2008-01-25 Servier Lab Nouveaux derives d'oximes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2898125B1 (fr) * 2006-03-06 2008-06-13 Servier Lab Nouveaux derives heterocycliques cycloalkyles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994015595A1 (en) * 1993-01-06 1994-07-21 Jemo-Pharm A/S Medium comprising a pharmacological/biological active substance
AU748608B2 (en) * 1997-05-01 2002-06-06 Bristol-Myers Squibb Company MTP inhibitors and fat soluble vitamin therapeutic combinations to lower serum lipid levels
US6020383A (en) * 1999-01-11 2000-02-01 Eastman Chemicals Company Method for reducing blood cholesterol and/or blood triglycerides
FR2804431A1 (fr) * 2000-02-02 2001-08-03 Adir Nouveaux derives heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DE10044805A1 (de) * 2000-09-11 2002-04-04 Martin Klingenberg Verwendung von Coenzym Q zur Regulierung der Funktion der Entkopplerproteine
CN1220488C (zh) * 2000-10-26 2005-09-28 爱尔兰福尼雅实验室有限公司 用于治疗内皮机能障碍的非诺贝特和辅酶q10组合物
JP2003116487A (ja) * 2001-10-15 2003-04-22 Beverly Corporation:Kk 痩身用食品
FR2845601B1 (fr) * 2002-10-11 2005-07-08 Servier Lab Nouvelle association entre un compose heterocyclique et un agent antioxydant et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
AU2005232420B2 (en) 2009-02-19
CA2563104A1 (fr) 2005-10-27
KR100842567B1 (ko) 2008-07-01
FR2868313B1 (fr) 2008-08-15
KR20060133073A (ko) 2006-12-22
AU2005232420A1 (en) 2005-10-27
HK1099689A1 (en) 2008-10-24
CN1938024A (zh) 2007-03-28
FR2868313A1 (fr) 2005-10-07
EA012966B1 (ru) 2010-02-26
AU2005232420B8 (en) 2009-06-11
AR048355A1 (es) 2006-04-19
WO2005099694A1 (fr) 2005-10-27
MA28467B1 (fr) 2007-03-01
EP1729767A1 (fr) 2006-12-13
GEP20094637B (en) 2009-03-10
ZA200607798B (en) 2008-05-28
UA86801C2 (ru) 2009-05-25
EA200601632A1 (ru) 2007-04-27
JP2007530643A (ja) 2007-11-01
MY142039A (en) 2010-08-30
CN100536842C (zh) 2009-09-09
US20070167502A1 (en) 2007-07-19
BRPI0509389A (pt) 2007-09-18
WO2005099694A8 (fr) 2006-11-09

Similar Documents

Publication Publication Date Title
AP2405A (en) Cannabinoid active pharmaceutical ingredient for improved dosage forms.
DK1940243T3 (da) Kostfiberformulering og fremgangsmåde til indgivelse
BRPI0821004A8 (pt) Composto derivado de aminopirazol, composição farmacêutica que o contem e uso deste
MX2008002492A (es) Composiciones farmaceuticas que comprenden un farmaco dependiente del ph, un modificador del ph, y un agente retardante.
NO20073026L (no) 2-alkoksy-3,4,5-trihydroksy-alkylamider, fremstilling og sammensetninger derav samt anvendelse derav
ECSP077999A (es) Formulaciones de una sal de bupropion de liberación modificada
NO20084253L (no) Tetrahydroisokinolinderivater for a forbedre hukommelsesfunksjon
BRPI0620229A8 (pt) formulação
WO2006138735A3 (en) Gel compositions for topical administration
FR2949062B1 (fr) Nouvelles formulations pharmaceutiques contre le mesusage des medicaments
NO20081160L (no) Benzimidazoltiofen forbindelser
NO20080220L (no) Formuleringer med hoy medikament belastning og doseringsformer
WO2006118884A3 (en) Drug delivery devices and related components, systems and methods
NO20082097L (no) Farmasoytiske sammensetninger
NO20090458L (no) Sukkerfrie, lagringsstabile antihistaminsaftpreparater
NO20074933L (no) Farmasoytisk sammensetning som innbefatter et indolylmaleimidderivat
NO20064808L (no) Orale matrixformuleringer med licarbazepin
SV2008003018A (es) Formulaciones medicamentosas que contienen fluoroquinolonas
TW200640491A (en) External preparation for transdermal administration containing nonsteroidal anti-inflammatory drug
NO20064783L (no) Opplosningstabeletter med licarbazepin
WO2007009691A3 (en) Combination of substituted pyrazolines and anti -addictive agent
IL186805A0 (en) Pharmaceutical compositions containing an active vitamin d compound
UY30065A1 (es) Composiciones farmacéuticas para la erradicación de helicobacter pylori
NO20064858L (no) Nye assosiasjon mellom en heterosyklisk forbindelse og et antioksidantmiddel, og farmasoytiske sammensetninger inneholdende dem
WO2008009802A3 (fr) Medicaments comprenant un inhibiteur des alpha-mannosidases de classe i pour le traitement des sarcoglycanopathies

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application